Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163555 | SCV000214113 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV003534428 | SCV000282751 | likely benign | Familial adenomatous polyposis 1 | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000163555 | SCV000681654 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001555066 | SCV001776420 | likely benign | not provided | 2019-12-03 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001555066 | SCV004219359 | likely benign | not provided | 2023-08-04 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004019959 | SCV004932122 | benign | Familial adenomatous polyposis 1 | 2024-03-26 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |